Skip to main content
. Author manuscript; available in PMC: 2022 Nov 28.
Published in final edited form as: Ann Surg Oncol. 2022 Mar 17;29(8):5207–5216. doi: 10.1245/s10434-022-11478-4

Figure 1:

Figure 1:

Comparison of Kaplan-Meier estimates of a) 5-year disease-specific survival curves and b) 5-year recurrence free survival curves between patients with brisk versus non-brisk versus absent tumor infiltration lymphocytes within their primary melanoma specimen.